| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1106943386 |
| P356 | DOI | 10.1186/S12977-018-0445-Y |
| P932 | PMC publication ID | 6134781 |
| P698 | PubMed publication ID | 30208933 |
| P50 | author | Rogier W Sanders | Q67472673 |
| P2093 | author name string | Alba Torrents de la Peña | |
| P2860 | cites work | Protein adaptations in archaeal extremophiles. | Q21285082 |
| The genomics of disulfide bonding and protein stabilization in thermophiles | Q24814780 | ||
| Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env | Q27644383 | ||
| Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies | Q27644515 | ||
| Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor | Q27651112 | ||
| Molecular architecture of native HIV-1 gp120 trimers | Q27651385 | ||
| Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors | Q27677104 | ||
| Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer | Q27680496 | ||
| Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. | Q46631754 | ||
| Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate | Q46775963 | ||
| Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers | Q47313525 | ||
| Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations | Q47549195 | ||
| The annual production cycle for influenza vaccine | Q47986917 | ||
| Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens. | Q49924212 | ||
| A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers | Q54237723 | ||
| Structural determinants of cold adaptation and stability in a large protein | Q73813239 | ||
| Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 | Q88985874 | ||
| Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. | Q41037927 | ||
| Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design | Q41042362 | ||
| Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers | Q41447893 | ||
| Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. | Q41611835 | ||
| Explanation of the stability of thermophilic proteins based on unique micromorphology | Q41856067 | ||
| Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design | Q42395228 | ||
| Structural determinants of the high thermal stability of SsoPox from the hyperthermophilic archaeon Sulfolobus solfataricus. | Q43026351 | ||
| Optimization of human immunodeficiency virus type 1 envelope glycoproteins with V1/V2 deleted, using virus evolution | Q43124783 | ||
| Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation | Q45421033 | ||
| High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers | Q46272894 | ||
| HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage | Q46454115 | ||
| Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer | Q27680497 | ||
| Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus | Q27680499 | ||
| Hepatitis C Virus E2 Envelope Glycoprotein Core Structure | Q27680704 | ||
| Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G | Q27704710 | ||
| Implications of aromatic-aromatic interactions: From protein structures to peptide models | Q28082108 | ||
| Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes | Q28271300 | ||
| A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies | Q28299280 | ||
| Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies | Q28553360 | ||
| HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers | Q28647225 | ||
| Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1) | Q28743199 | ||
| Pre-fusion structure of a human coronavirus spike protein. | Q30385177 | ||
| A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure | Q33592001 | ||
| Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein | Q33711154 | ||
| HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies | Q33753573 | ||
| Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions | Q33789251 | ||
| Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches | Q33830824 | ||
| Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution | Q34299053 | ||
| Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant | Q34301874 | ||
| Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. | Q34361680 | ||
| A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism | Q34492100 | ||
| Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution | Q34611144 | ||
| Reconsideration of an early dogma, saying "there is no evidence for disulfide bonds in proteins from archaea". | Q34629088 | ||
| Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures | Q35105223 | ||
| A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene | Q35110976 | ||
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Q35142291 | ||
| Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties | Q35540033 | ||
| HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies | Q35640998 | ||
| Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env. | Q35641498 | ||
| Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort | Q35894094 | ||
| The HIV-1 envelope protein gp120 is captured and displayed for B cell recognition by SIGN-R1(+) lymph node macrophages | Q36071444 | ||
| Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity | Q36086357 | ||
| Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity | Q36094699 | ||
| Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens | Q36102994 | ||
| Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env. | Q36104987 | ||
| Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C. | Q36132706 | ||
| Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants | Q36246646 | ||
| HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. | Q36345558 | ||
| Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape | Q36388754 | ||
| Amino-acid interactions in psychrophiles, mesophiles, thermophiles, and hyperthermophiles: insights from the quasi-chemical approximation | Q36393540 | ||
| Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer. | Q36409575 | ||
| Lessons in stability from thermophilic proteins | Q36525476 | ||
| Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies | Q36750045 | ||
| Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B. | Q36821375 | ||
| Differences in amino acids composition and coupling patterns between mesophilic and thermophilic proteins | Q36915097 | ||
| High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells. | Q36957800 | ||
| Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. | Q37060986 | ||
| Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV | Q37095226 | ||
| Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers | Q37123501 | ||
| Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein | Q37123584 | ||
| Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation | Q37157165 | ||
| Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies | Q37246321 | ||
| HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies | Q37293480 | ||
| Nature Versus Nurture: Developing Enzymes That Function Under Extreme Conditions | Q37999040 | ||
| Virus-like particle-based human vaccines: quality assessment based on structural and functional properties | Q38152530 | ||
| Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires | Q38747466 | ||
| Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem | Q39108730 | ||
| Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development | Q39108751 | ||
| The HIV-1 envelope glycoprotein structure: nailing down a moving target | Q39108789 | ||
| Identification and specificity of broadly neutralizing antibodies against HIV | Q39108796 | ||
| HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike | Q39365785 | ||
| A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure | Q39588870 | ||
| Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers | Q39602726 | ||
| Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer | Q39949085 | ||
| Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization | Q40073525 | ||
| Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. | Q40083207 | ||
| Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1. | Q40210715 | ||
| Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity | Q40301176 | ||
| Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers. | Q40471380 | ||
| Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies | Q40568483 | ||
| A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans. | Q40606158 | ||
| Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique | Q40639803 | ||
| Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer | Q40957217 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| globulins | Q321710 | ||
| blood proteins | Q425056 | ||
| viral protein | Q952587 | ||
| neutralizing antibody | Q7003054 | ||
| virology | Q7215 | ||
| infectious disease | Q18123741 | ||
| viral envelope proteins | Q66008752 | ||
| P304 | page(s) | 63 | |
| P577 | publication date | 2018-09-12 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Retrovirology | Q15793508 |
| P1476 | title | Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies | |
| P478 | volume | 15 |
| Q89708295 | A Systematic Approach to HIV-1 Vaccine Immunogen Selection |
| Q94458567 | HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies |
| Q92093979 | Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin |
| Q92327047 | Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1 |
| Q90211541 | Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice |
| Q91609981 | Strategies for inducing effective neutralizing antibody responses against HIV-1 |
| Q92382176 | Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence |
| Q92478519 | V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers |
Search more.